Avantax Advisory Services Inc. increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 5.7% ...

Fintel reports that on March 21, 2025, Cantor Fitzgerald initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a ...

Although LFSC launched just five months ago, the team at Emerald Advisers is highly experienced. Read why I don't recommend ...

Detailed price information for S&P Biotech SPDR (XBI-A) from The Globe and Mail including charting and trades.

Shares in financial firm Stifel (SF) dropped 3% today after it was told to cough up $132.5 million in damages to a U.S.

Fintel reports that on March 12, 2025, Evercore ISI Group initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a ...

In particular, the stock is up 34% since our amended Form 13D filing on October 24, 2024, while the Nasdaq Biotechnology Index (NBI) is down 4% over the same period and the SPDR S&P Biotech ETF (XBI) ...

With a ratio of 0.09%, the SPDR S&P 500 ETF largely fits the bill. Now, we'll consider this ETF specifically and whether it's a smart buy for you. The SPDR S&P 500 ETF tracks the S&P 500's ...

SPDR S&P 500 ETF Trust was the start of the exchange-traded fund revolution. The ETF landscape has changed dramatically since SPDR S&P 500 ETF Trust was the only ETF an investor could buy. Today ...

SPDR S&P 500 ETF Trust (NYSEMKT: SPY) will always have a special place in the history of Wall Street. That's because the exchange-traded fund (ETF) was the first of its kind. But the ETF market ...